Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.000
-0.020 (-0.99%)
Nov 18, 2026, 1:02 PM EST - Market open
Compugen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 75.93 | 72.76 | 27.86 | 33.46 | 7.5 | 6 | |
Revenue Growth | 999.97% | 161.14% | -16.72% | 346.12% | 25.00% | 200.00% |
Cost of Revenue | 10.45 | 9.25 | 7.93 | 2 | 0.98 | 0.68 |
Gross Profit | 65.48 | 63.51 | 19.93 | 31.46 | 6.53 | 5.32 |
Selling, General & Admin | 9.5 | 9.43 | 10.02 | 9.98 | 11.25 | 11.7 |
Research & Development | 24.63 | 22.76 | 24.81 | 34.47 | 30.65 | 28.69 |
Operating Expenses | 34.13 | 32.19 | 34.83 | 44.45 | 41.9 | 40.39 |
Operating Income | 31.34 | 31.33 | -14.89 | -12.99 | -35.37 | -35.07 |
Interest & Investment Income | 4.88 | 3.91 | 3.49 | 2.96 | 1.44 | 0.89 |
Currency Exchange Gain (Loss) | -0.31 | -0.31 | -0.02 | 0.01 | 0.34 | -0 |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
EBT Excluding Unusual Items | 35.89 | 34.89 | -11.46 | -10.06 | -33.62 | -34.21 |
Gain (Loss) on Sale of Investments | 0.5 | 0.5 | 1.75 | 0.28 | - | - |
Gain (Loss) on Sale of Assets | 0 | 0 | - | -0.01 | -0.01 | 0 |
Pretax Income | 36.39 | 35.4 | -9.71 | -9.78 | -33.64 | -34.2 |
Income Tax Expense | 0.02 | 0.05 | 4.52 | 8.97 | 0.06 | - |
Net Income | 36.37 | 35.34 | -14.23 | -18.75 | -33.69 | -34.2 |
Net Income to Common | 36.37 | 35.34 | -14.23 | -18.75 | -33.69 | -34.2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 95 | 93 | 90 | 88 | 87 | 84 |
Shares Outstanding (Diluted) | 95 | 94 | 90 | 88 | 87 | 84 |
Shares Change | 2.96% | 4.79% | 2.16% | 1.24% | 2.79% | 5.80% |
EPS (Basic) | 0.38 | 0.38 | -0.16 | -0.21 | -0.39 | -0.41 |
EPS (Diluted) | 0.38 | 0.38 | -0.16 | -0.21 | -0.39 | -0.41 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 31.33 | 49.49 | -36.06 | -34.59 | -22.98 |
Free Cash Flow Per Share | - | 0.33 | 0.55 | -0.41 | -0.40 | -0.27 |
Gross Margin | 86.23% | 87.29% | 71.54% | 94.01% | 87.00% | 88.67% |
Operating Margin | 41.28% | 43.05% | -53.44% | -38.83% | -471.65% | -584.57% |
Profit Margin | 47.90% | 48.57% | -51.07% | -56.05% | -449.25% | -570.05% |
Free Cash Flow Margin | - | 43.05% | 177.60% | -107.77% | -461.20% | -383.05% |
EBITDA | 31.81 | 31.8 | -14.41 | -12.52 | -34.89 | -34.61 |
EBITDA Margin | 41.89% | 43.70% | -51.70% | -37.41% | - | - |
D&A For EBITDA | 0.47 | 0.48 | 0.49 | 0.48 | 0.48 | 0.46 |
EBIT | 31.34 | 31.33 | -14.89 | -12.99 | -35.37 | -35.07 |
EBIT Margin | 41.28% | 43.05% | -53.44% | -38.83% | - | - |
Effective Tax Rate | 0.06% | 0.15% | - | - | - | - |